ArticleThe oncologist2021

Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid Tumors.

Her-Shyong Shiah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.